期刊
CANCERS
卷 13, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/cancers13051100
关键词
CAFs; FAP; theranostics; radionuclide therapy
类别
资金
- KWF Kankerbestrijding
- Erasmus MC
- TU Delft
Cancer Associated Fibroblasts (CAFs) are a crucial component of the tumor microenvironment with complex origins and diverse functions, making them an appealing target for novel therapeutic interventions in cancer. Despite some limitations in translating CAF-targeting interventions from research to clinical use, promising developments have been made, particularly in targeting Fibroblast Activation Protein (FAP) on CAFs for improved cancer diagnosis and treatment.
Simple Summary The tumour microenvironment contains a unique population of cells, of complex origin and diverse functionality, known as Cancer associated fibroblasts (CAFs). In recent years there has been a growing interest in targeting CAFs to aid cancer diagnosis and therapy. Amongst the approaches utilized so far, targeting Fibroblast activation protein (FAP) has shown a lot of promise. In this review, we will focus on our current knowledge of the biology of CAFs as well as theranostic applications that will enhance cancer diagnosis and therapy in cancers carrying a distinct CAF signature. Cancer Associated Fibroblasts (CAFs) form a major component of the tumour microenvironment, they have a complex origin and execute diverse functions in tumour development and progression. As such, CAFs constitute an attractive target for novel therapeutic interventions that will aid both diagnosis and treatment of various cancers. There are, however, a few limitations in reaching successful translation of CAF targeted interventions from bench to bedside. Several approaches targeting CAFs have been investigated so far and a few CAF-targeting tracers have successfully been developed and applied. This includes tracers targeting Fibroblast Activation Protein (FAP) on CAFs. A number of FAP-targeting tracers have shown great promise in the clinic. In this review, we summarize our current knowledge of the functional heterogeneity and biology of CAFs in cancer. Moreover, we highlight the latest developments towards theranostic applications that will help tumour characterization, radioligand therapy and staging in cancers with a distinct CAF population.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据